Sofwave Participate in LifeSci Partners HealthTech Symposium

2 years ago

Virtual fireside chat to take place on Wednesday, September 21, 2022 at 11:00 a.m. ETSAN CLEMENTE, Calif., Sept. 20, 2022…

Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™ Compositions

2 years ago

CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize…

Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web Site

2 years ago

SAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR) (“Eargo”, the “Company,” “we,” or “us”), a…

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development

2 years ago

Advanced insights from CytoReason’s disease models will support Pfizer’s drug development processTEL AVIV, Israel, Sept. 20, 2022 (GLOBE NEWSWIRE) --…

Benefytt Technologies Appoints Jaclyn Hill as Chief Operating Officer

2 years ago

TAMPA, Fla., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Benefytt Technologies, Inc. (“Benefytt” or the “Company”), a health insurance technology company…

Avricore Health Announces CEO Update Call on Sept. 22, 2022

2 years ago

VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to…

Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland

2 years ago

Reimbursement granted with no restrictions to the labelATLANTA, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”),…

Albireo to Participate in Guggenheim Nantucket Therapeutics Conference

2 years ago

BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company developing novel bile acid…

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

2 years ago

Saudi Food & Drug Authority approval propels Sientra international expansion into the GCC and Middle East regionSANTA BARBARA, Calif., Sept.…

Applied Molecular Transport Completes Enrollment of Phase 2 LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis

2 years ago

Top-line data readout anticipated late 2022 or early 2023SOUTH SAN FRANCISCO, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Applied Molecular…